14A-1110810
USP
This study discovered that galactolipid-enriched extract of Crassocephalum rabens (designated CRA) can function as a vaccine adjuvant. CRA dramatically enhanced specific antibody titers and increased the proportions of IgG2a, IgG2b, and IgG3 in the total immunoglobulins (Ig) in mouse serum. CRA induces IL-21 and B cell-activating factor (BAFF) to promote B cell differentiation. CRA also
enhanced cell proliferation, uptake ability, and antigen presentation in mouse phagocytes. Taken together, this invention repprts that C. rabens-derived CRA functions as an adjuvant that enhances mouse immunity against foreign antigens due to the increase of antigen presentation by antigen-presenting cells and the promotion of B cell differentiation, in turn, specific antibodies with higher titer and affinity were produced.
- Phytogalactolipids increase the titers of specific antibodies by promoting B cell differentiation.
- Phytogalactolipids enhance the affinity of specific antibodies by inducing antibody class-switching.
- Phytogalactolipids increase the cell proliferation, phagocytic ability and antigen presentation of antigen-presenting cells.
1. bacterial vaccine adjuvant
2. viral vaccine adjuvant
3. cancer vaccine adjuvant
Yu-Ling Lin, Li-Fen Shyur
If you are interested in this technology, please fill in the information on the webpage under the manufacturer option (Request for Technology Licensing, Material Transfer, or Sponsored Research) on the website of this office

A plant galactolipid-based adjuvant